Replies to post #2565 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

IDIX Insider Shareholdings

[Updated for resignation of Norman Payson from BoD
(#msg-33971276). Options listed below include both
vested and non-vested holdings.]

 
 Executive Officers  
 JP Sommadossi, CEO       2,220K shares  1,406 options 
 Ron Renaud, CFO             15K shares   345K options 
 Doug Mayers, CMO            30K shares   220K options 
 David Standring, EVP Bio      0 shares    70K options 
 John Weidenbruch, Gen Cnsl  15K shares   185K options 
 Paul Fanning, SVP Human Rsrcs 0 shares    40K options 
 -- 
 Six executive officers   2,280K shares 2,266K options

 
 Independent directors  
 Charles Cramb                7K shares   120K options 
 Wayne Hockmeyer             42K shares    80K options 
 Thomas Hodgson              42K shares    80K options 
 Denise Pollard-Knight         0 shares    60K options 
 Pamela Thomas-Graham          0 shares    95K options 
 -- 
 Five independent dirctrs    91K shares   435K options

 
 All officers/directors   2,371K shares 2,701K options